CIDRAP newsletters options
The WHO notes 15 new deaths, but it revised the number of confirmed deaths downward.
The US Food and Drug Administration (FDA) has issued a warning to GlaxoSmithKline (GSK) over cleanliness shortcomings at its plant in Ste. Foy, Quebec, which makes Canada's seasonal flu vaccine, the Canadian Press reported today.
Early results of environmental tests at CDC labs are negative.
With 18,519 new cases, the number of suspected or confirmed cases reaches 189,055.
Clinical virology experts call for systematic monitoring patients, as Saudi Arabia reports 2 new cases.
The lion's share of cases have been in Sierra Leone, and MSF calls the outbreak "out of control."
The US Food and Drug Administration (FDA) has approved tedizolid phosphate (Sivextro), a new antibacterial drug to treat adults with acute bacterial skin and skin structure infections (ABSSSI), the agency announced on Jun 20.
Wild poliovirus type 1 (WPV1) has been isolated from sewage samples in Sao Paulo state in Brazil, the World Health Organization (WHO) reported yesterday.
The samples were collected in March at the Viracopos International Airport in Campinas in the southeastern part of the country. Tests at a national lab confirmed the virus on Jun 18, the WHO said in a statement.
Nine more workers may have been exposed to Bacillus anthracis.
The flu vaccine in three European nations in 2012-13 provided 33% protection against hospitalization for influenza in adults, according to a study yesterday in PLoS One.
Saudi Arabia reported one new MERS-CoV (Middle East respiratory syndrome coronavirus) case today, raising the country's official total to 706 cases.
The latest patient is a 45-year-old expatriate who is hospitalized in Riyadh, the Ministry of Health (MOH) said in today's update. He has no preexisting conditions and is not a healthcare worker. The ministry gave no information about how he was exposed to the virus.
The CDC is monitoring and providing antibiotics to about 75 staffers over Bacillus anthracis concerns.
The IDSA stressed that many infections heal on their own or don't need antibiotics.
Further testing appears to show that a Bangladeshi case reported 4 days ago was not MERS.
Is there a unique public health benefit of gain-of-function studies, unachievable by safer means, that outweighs their risk?
An outbreak of an unknown febrile illness that initially prompted suspicion for hemorrhagic fever or Middle East respiratory syndrome coronavirus (MERS-CoV) has been diagnosed as dengue fever, the World Health Organization (WHO) said yesterday in a statement.
Morocco's health minister advises Muslims in his country not to go on pilgrimage to Saudi Arabia.
It is now the largest, deadliest Ebola outbreak on record.
A fatal case of H5N1 avian flu has been reported in Indonesia, according to a story in the Jakarta Post today. This represents the second confirmed human case of the highly pathogenic strain of avian influenza in the country this year.
Syria's eighth vaccination campaign in as many months begins this week and hopes to reach 2.8 million children over 5 days, according to a news release yesterday from the World Health Organization's (WHO's) Regional Office for the Eastern Mediterranean.
